Chantana Polprasert

13PUBLICATIONS
49CO-AUTHORS
Gene and molecular therapyMedical biotechnology diagnostics (incl. biosensors)Cancer diagnosisTumour immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 16, 2026
Real-World Outcomes of Hypomethylating Agents for Higher-Risk Myelodysplastic Syndromes: Report From the Nationwide Multicenter Thai MDS Study.

|Aug 09, 2026
Laboratory Concordance and Prognostic Impact of 10-Color Flow Cytometry and Next-Generation Sequencing-Based Immunoglobulin Gene Assay for Measurable Residual Disease Monitoring in Adult B-Cell Acute Lymphoblastic Leukemia: A Multicenter Study From Thai Acute Leukemia Working Group (TALWG).

|Oct 08, 2025
Optimizing Markers for Chronic Lymphocytic Leukemia Diagnosis by Flow Cytometry: Results From the Nationwide Thai Lymphoma Study Group.

Ornnicha Sathitakorn, Sirorat Kobbuaklee, Chantiya Chanswangphuwana

|Nov 13, 2024
Characteristics and therapeutic outcomes of subcutaneous panniculitis-like T-cell lymphoma with and without germline HAVCR2 mutations in Thai children and adolescents.

Pimpitcha Youthong, Samart Pakakasama, Patcharee Komvilaisak

|Aug 06, 2024
T-PLL Presenting with an Indolent Course.

Arsa Thammahong, Narittee Sukswai, Chantana Polprasert

|Dec 15, 2022
Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms.

Chantana Polprasert, Pimjai Niparuck, Thanawat Rattanathammethee

Pageof 3

Frequent Collaborators

4 joint publications

Chatphatai Moonla

4 joint publications

Ponlapat Rojnuckarin

3 joint publications

Weerapat Owattanapanich

2 joint publications

Thanawat Rattanathammethee